Ivax Diagnostics, Inc. (IVD) Reports Q3 Loss of $0.04, Flat Y/Y
Ivax Diagnostics, Inc. (NYSE: IVD) reported Q3 EPS of ($0.04), versus ($0.04) reported last year. Revenue for the quarter came in at $4.06 million, versus $3.95 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ExxonMobil (XOM) Tops Q3 EPS by 18c
- AbbVie (ABBV) Tops Q3 EPS by 12c
- Intermolecular (IMI) Tops Q3 EPS by 2c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!